Short‐term efficacy of tacrolimus in steroid‐refractory ulcerative colitis – experience in 130 patients
K. J. Schmidt(University Hospital Schleswig-Holstein), Jürgen Büning(University Hospital Schleswig-Holstein), Klaus Fellermann(Apple (Israel)), K Herrlinger(Robert Bosch Hospital), H. Lehnert(University Hospital Schleswig-Holstein), Daniel Nicolas Barthel(Robert Bosch Hospital), Eduard F. Stange(John Radcliffe Hospital), Jörg Emmrich(University of Rostock), Hülya Koç
Cited by 84
Related Papers
Reduced Paneth cell α-defensins in ileal Crohn's disease
|Proceedings of the National Academy of Sciences|2005|969
NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression
|Gut|2004|798
A Chromosome 8 Gene-Cluster Polymorphism with Low Human Beta-Defensin 2 Gene Copy Number Predisposes to Crohn Disease of the Colon
|The American Journal of Human Genetics|2006|566
European evidence-based Consensus on the management of ulcerative colitis: Current management
|Journal of Crohn s and Colitis|2008|558